Cationic Lipid-based Intracellular Delivery of Bacterial Effectors for Rewiring Malignant Cell Signaling.

Angewandte Chemie
Shaojun YangPeng R Chen

Abstract

The abundance of bacterial effectors have inspired us to explore their potential in rewiring malignant cell signaling. Their incapability for entering cells, however, hinders such application. Herein we developed a cationic lipid-based high throughput library screening platform for effective intracellular delivery of bacterial effectors. As the misregulated MAPK signaling is a hallmark of many types of cancer, we turned to the Shigella effector OspF which irreversibly inactivates ERK, the terminal component of MAPK cascade. We created a function-based screening assay to obtain AMPA-O16B lipid nanoparticles for effective OspF intracellular delivery, which inhibited the malignant MAPK signaling and tumor growth in vitro and in vivo. Furthermore, the optimized lipid nanoparticle formulation can deliver OspF to modulate the immunosuppressive responses in macrophages. Our work is a general strategy to explore the therapeutic potentials of naturally evolved bacterial effectors.

References

Mar 1, 1992·Molecular and Cellular Biology·R H ChenJ Blenis
Feb 28, 2002·Annual Review of Immunology·Chen DongRichard A Flavell
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Mar 8, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonio SicaPaola Allavena
Nov 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Caroline M EmeryLevi A Garraway
Jan 15, 2010·Current Opinion in Microbiology·Christopher A Broberg, Kim Orth
Feb 16, 2010·Nature Reviews. Immunology·Margarida Saraiva, Anne O'Garra
Jul 16, 2010·The Biochemical Journal·Ana Cuadrado, Angel R Nebreda
Nov 30, 2010·Cell·David Ribet, Pascale Cossart
Dec 27, 2011·Nature Chemical Biology·Solveigh C KoeberleStefan A Laufer
Oct 6, 2012·Advanced Drug Delivery Reviews·Theresa M Allen, Pieter R Cullis
Jan 8, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ryan J Sullivan, Keith T Flaherty
Apr 16, 2014·Journal of Nanoscience and Nanotechnology·Sudipta Mallick, Joon Sig Choi
Aug 12, 2014·Nature Reviews. Drug Discovery·Samir MitragotriRobert Langer
Dec 2, 2014·Nature Reviews. Drug Discovery·Ahmed A Samatar, Poulikos I Poulikakos
Mar 31, 2015·Nature Communications·Alexander PlotnikovRony Seger
Apr 11, 2015·Cancer Cell·Brian Ruffell, Lisa M Coussens
Jul 19, 2015·Cancer Letters·Mark H ManninoYujiang Fang
Mar 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Ming WangQiaobing Xu
Oct 11, 2016·Chemical Society Reviews·N GrimaldiN Ventosa
Jan 25, 2017·Nature Reviews. Clinical Oncology·Alberto MantovaniPaola Allavena
Jul 30, 2017·Nature Chemistry·Misao AkishibaShiroh Futaki
Oct 27, 2018·Nature Reviews. Drug Discovery·Luca Cassetta, Jeffrey W Pollard
Nov 6, 2018·Journal of the American Chemical Society·Shubo DuShao Q Yao
Dec 1, 2018·Nature Reviews. Drug Discovery·Aaron C AnselmoSamir Mitragotri
Jun 14, 2019·Molecular Carcinogenesis·Rachel M SammonsKevin N Dalby
Jul 28, 2019·Biomaterials·Jia LvYiyun Cheng
Aug 14, 2019·Angewandte Chemie·Angela P BlumNathan C Gianneschi
Oct 8, 2019·Journal of the American Chemical Society·Jin ChangMing Wang
Oct 16, 2019·Proceedings of the National Academy of Sciences of the United States of America·Hejia Henry Wang, Andrew Tsourkas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.